Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 63, 2003 - Issue 4
Submit an article Journal homepage
11
Views
3
CrossRef citations to date
0
Altmetric
Original article

Fasting triglycerides as a predictor of long‐term mortality in middle‐aged men with combined hyperlipidaemia

E. M. Hjerkinn Research ForumCorrespondence[email protected]
,
L. Sandvik Competence Center for Clinical Research
,
I. Hjermann the Department of Preventive Cardiology, Ullevaal University Hospital, Oslo, Norway
&
H. Arnesen Research Forum
Pages 273-278 | Received 15 Nov 2002, Accepted 06 May 2003, Published online: 08 Jul 2009

REFERENCES

  • Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based pro-spective studies. J Cardiovasc Risk 1996; 3: 213–9.
  • Avins AL, Neuhaus JM. Do triglycerides provide meaningful information about heart disease risk? Arch Intern Med 2000; 160: 1937–44.
  • Hjermann I, Velve BK, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet 1981; 2: 1303–10.
  • Hjermann I, Leren P, Norman N, Helgeland A, Holme I. Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men: the Oslo study. Scand J Clin Lab Invest 1980; 40: 89–94.
  • Leren P, Askevold EM, Foss OP, Froili A, Grymyr D, Helgeland A, et al. The Oslo study. Cardiovascular disease in middle-aged and young Oslo men. Acta Med Scand 1975; Suppl. 588: 1–38.
  • Hjermann I, Velve BK, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet 1981; 2: 1303–10.
  • Hjermann I, Leren P, Norman N, Helgeland A, Holme I. Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men: the Oslo study. Scand J Clin Lab Invest 1980; 40: 89–94.
  • Haider T, Foss OP. The analytical variation and mean difference of serum lipid values in duplicate samples subjected to different times of storage. Scand J Clin Lab Invest 1983; 43: 439–43.
  • Cox DR. Regression model and life table. J R Stat Stoc 1972; (B:34): 187.
  • SPSS for Windows, version 10.07 (1 June 2000). SPSS Inc. 1989-1999. 2002.
  • Erikssen G, Liestol K, Bjornholt J, Thaulow E, Sandvik L, Erikssen J. Changes in physical fitness and changes in mortality. Lancet 1998; 352: 759–62.
  • Assmann G, Schulte H. Role of triglycerides in coronary artery disease: lessons from the Prospec-tive Cardiovascular Munster Study. Am J Cardiol 1992; 70: 10H— 13H.
  • Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen O, Frick H. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implica-tions for treatment. Circulation 1992; 85: 37–45.
  • Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenha-gen Male Study. [Erratum appears in Circulation 1998; May 19; 97(19): 1995]. Circulation 1998; 97: 1029— 36.
  • Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based pro-spective studies. J Cardiovasc Risk 1996; 3: 213–9.
  • Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Prey Med 1986; 15: 254–73.
  • The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351 — 64.
  • Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. The Lipid Research Clinics Program Epidemiology Committee. Circulation 1979; 60: 427–39.
  • Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenha-gen Male Study. [Erratum appears in Circulation 1998; May 19; 97(19): 1995]. Circulation 1998; 97: 1029— 36.
  • Jacobs DR Jr, Barrett-Connor E. Retest reliability of plasma cholesterol and triglyceride. The Lipid Research Clinics Prevalence Study. Am J Epide-miol 1982; 116: 878–85.
  • Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998; 81(4A): 18B–25B.
  • Yudkin JS, Coppack S. Insulin resistance and impaired glucose tolerance. Lancet 1994; 344: 1294 — 5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.